Gene co-expression network analysis of the GSE263867 dataset. by Yaping Yuan (2734228)

Flow Chart of Study Participant Selection. by Zhi Jin (3742471)

“…Notably, individuals with long sleep duration (>9 hours) had a significantly decreased risk of CVD (OR: 0.36, 95% CI: 0.15–0.85, P = 0.02) compared to those with shorter sleep durations.…”

Organic solvent exposure causes defects in salt chemotaxis learning. by Masahiro Tomioka (430683)

Data - willing to pay of dog owners. by Fentahun Mengie (20862454)

“…Male dog owners and dog owners belonging to lower age groups had significantly higher AT towards leashing dogs. …”

Data - intention of dog owners. by Fentahun Mengie (20862454)

“…Male dog owners and dog owners belonging to lower age groups had significantly higher AT towards leashing dogs. …”

Map of the study area (shaded in gray). by Fentahun Mengie (20862454)

“…Male dog owners and dog owners belonging to lower age groups had significantly higher AT towards leashing dogs. …”

Expression profile of WRKY-TFs and ROS accumulation in susceptible T200 and tolerant TME3 cassava genotypes. by Bulelani L. Sizani (21485746)

Transcript levels of MAPK, NIK, NLR and SA-depended gene pathways and responsive genes. by Bulelani L. Sizani (21485746)

Transcript levels of MAPK, NIK, NLR and SA-dependent gene pathways and responsive genes. by Bulelani L. Sizani (21485746)

South African cassava mosaic virus (SACMV) genome structure and the effect of SACMV on cassava leaf symptoms. by Bulelani L. Sizani (21485746)

Impact on different areas of health. by Margherita Molaro (17803989)

Clinical characteristics. by Clemens Plattner (21567706)

“…Survival curves were estimated using the Kaplan-Meier plot and compared using the Log-rank test.</p><p>Results</p><p>Mean age at T2D diagnosis was significantly lower in the FHD group, while time to insulin initiation was independent from FHD status. …”

ONSD at T14 and six months after ICU discharge. by Marco Carbonara (11483575)

Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

Subjects:

Median EQ-5D-3L index values during 5 years of follow-up. by Karl Ingard (22582091)

Subjects:

Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

Subjects:

Subgroup Analysis of the Occurrence of Secondary Endpoints. by Karl Ingard (22582091)

Subjects:

Study flow chart. by Karl Ingard (22582091)

Subjects:

Kaplan-Meier curve of the primary outcome. by Karl Ingard (22582091)

Subjects:

Number of Patients Who Reached the Primary and Secondary Endpoints During Follow-up. by Karl Ingard (22582091)

Subjects: